Micro RNAs in septic acute kidney injury: pathophysiology, biomarkers and therapeutic targets
Folia Medica · 03.04.2026 · 68 (2)
DOI: 10.3897/folmed.68.e166581 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Folia Medica, online erschienen am 03.04.2026. Verfasst von Georgi Nikolov und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Nephrology, University hospital St. Georgi, Medical University Plovdiv, Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Acute Kidney Injury, MicroRNAs, Sepsis, Inflammation. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Septic acute kidney injury (S-AKI) is a life-threatening complication of sepsis with high mortality and limited treatment options. Emerging evidence highlights the role of microRNAs (miRNAs) as critical regulators of the key pathogenic pathways involved in S-AKI, including inflammation, apoptosis, oxidative stress, and microvascular dysfunction.
Aim
To provide a comprehensive overview of the current knowledge of miRNA involvement in the pathophysiology, diagnosis, and potential treatment of S-AKI. Materials and methods : A structured literature review was conducted using recent experimental and clinical studies published in peer-reviewed journals from 2018 to 2025. Key miRNAs implicated in S-AKI were identified and analyzed for their diagnostic and therapeutic relevance.
Results
Several miRNAs, such as miR-155, miR-146a/b, miR-21, miR-210, and miR-22-3p, modulate essential signaling cascades in S-AKI, either promoting or attenuating kidney injury depending on context. Circulating and urinary miRNAs demonstrate high sensitivity and specificity as early biomarkers, often outperforming traditional markers like serum creatinine. Furthermore, experimental models show that targeting specific miRNAs using mimics or antagonists can significantly mitigate renal damage in sepsis. Conclusion : miRNAs offer a promising dual application in S-AKI—as sensitive noninvasive biomarkers and as novel therapeutic targets. Future research should focus on validating their clinical utility and overcoming challenges related to targeted delivery and off-target effects. miRNA-based interventions may become integral components of personalized therapy in sepsis-related kidney injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinic of Nephrology, University hospital St. Georgi, Medical University Plovdiv, Plovdiv, Bulgaria.
- Paisii Hilendarski University of Plovdiv, Plovdiv, Bulgaria.
- Medical University, Plovdiv, Bulgaria.
ORCID-Profile: Georgi Nikolov, Chavdar Stefanov
Zitieren
APA
Nikolov, G., Nikolov, D., Naydenov, M., & Stefanov, C. (2026). Micro RNAs in septic acute kidney injury: pathophysiology, biomarkers and therapeutic targets. Folia Medica, 68(2). https://doi.org/10.3897/folmed.68.e166581
Vancouver
Nikolov G, Nikolov D, Naydenov M, Stefanov C. Micro RNAs in septic acute kidney injury: pathophysiology, biomarkers and therapeutic targets. Folia Medica. 2026;68(2). doi:10.3897/folmed.68.e166581
BibTeX
@article{Nikolov2026,
author = {Nikolov, Georgi and Nikolov, Dimitar and Naydenov, Mladen and Stefanov, Chavdar},
title = {Micro RNAs in septic acute kidney injury: pathophysiology, biomarkers and therapeutic targets},
journal = {Folia Medica},
year = {2026},
volume = {68},
number = {2},
doi = {10.3897/folmed.68.e166581}
}
EUVIMED